SEEMA KAZI
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- EULESS, TX
- NPI
- 1780606772
- Received
- $7,459 in 371 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 121 | $2,501 |
| 2024 | General payment | 38 | $929 |
| 2023 | General payment | 26 | $717 |
| 2022 | General payment | 29 | $551 |
| 2021 | General payment | 53 | $1,066 |
| 2020 | General payment | 29 | $433 |
| 2019 | General payment | 75 | $1,258 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 367 | $7,160 |
| Education | 4 | $298 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-16 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-12-15 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-12-10 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-03 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-24 | Alkermes, Inc. | $34 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-19 | Neurocrine BioSciences, Inc. | $34 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-08 | Alkermes, Inc. | $3 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-11-04 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-04 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-28 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-27 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-21 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-10-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Eisai Inc. | $21 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-10-15 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-14 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-13 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-10-07 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-09-30 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-29 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-12 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $8 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-03 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-20 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-19 | Collegium Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-19 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | Supernus Pharmaceuticals, Inc. | $14 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-11 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-05 | Alkermes, Inc. | $31 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-08-04 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | Alkermes, Inc. | $14 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-07-25 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-23 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-07-21 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-16 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-07 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-07-02 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-30 | Collegium Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-06-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | Alkermes, Inc. | $33 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-06-17 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-06-16 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-11 | Noven Therapeutics, LLC | $13 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-06-09 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-04 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-30 | Neurocrine BioSciences, Inc. | $35 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-23 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-19 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-06 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-05-05 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-29 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-29 | E.R. Squibb & Sons, L.L.C. | $13 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-29 | E.R. Squibb & Sons, L.L.C. | $10 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-28 | Validus Pharmaceuticals LLC | $18 | Food and Beverage | Cash or cash equivalent | RALDESY Drug, CNS | 2025 | |
| 2025-04-21 | Collegium Pharmaceutical, Inc. | $20 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-04-16 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-15 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-14 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-08 | Corium, LLC | $33 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2025 | |
| 2025-04-07 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-04 | Neurocrine BioSciences, Inc. | $1 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-02 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-31 | Teva Pharmaceuticals USA, Inc. | $109 | Education | In-kind items and services | 2025 | ||
| 2025-03-31 | Noven Therapeutics, LLC | $15 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-03-31 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-03-27 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-24 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-17 | Alkermes, Inc. | $32 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-03-11 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-26 | Boehringer Ingelheim Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-25 | Lundbeck LLC | $22 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-25 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-24 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-02-19 | Validus Pharmaceuticals LLC | $20 | Food and Beverage | Cash or cash equivalent | EQUETRO Drug, CNS | 2025 | |
| 2025-02-18 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-02-18 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-17 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-17 | LivaNova USA, Inc. | $20 | Food and Beverage | In-kind items and services | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR Device, Neurology | 2025 | |
| 2025-02-12 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-11 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-09 | Collegium Pharmaceutical, Inc. | $17 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-02-05 | Corium, LLC | $31 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2025 | |
| 2025-02-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-04 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-30 | Janssen Pharmaceuticals, Inc | $26 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-27 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-01-23 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-21 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-01-20 | Tris Pharma Inc | $21 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-01-17 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-08 | Neurocrine BioSciences, Inc. | $124 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-07 | IDORSIA PHARMACEUTICALS US INC | $20 | Food and Beverage | In-kind items and services | Quviviq Drug, Insomnia | 2025 | |
| 2025-01-07 | Neurocrine BioSciences, Inc. | $2 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-06 | LivaNova USA, Inc. | $20 | Food and Beverage | In-kind items and services | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR Device, Neurology | 2025 | |
| 2024-12-10 | IRONSHORE PHARMACEUTICALS INC. | $15 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-12-08 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-03 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-12-02 | Neurocrine BioSciences, Inc. | $35 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-26 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-11-19 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-13 | Corium, LLC | $31 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-10-21 | Neurocrine BioSciences, Inc. | $36 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-15 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-10-14 | IRONSHORE PHARMACEUTICALS INC. | $14 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-10-07 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-11 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-28 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-08-21 | IRONSHORE PHARMACEUTICALS INC. | $15 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-08-07 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-31 | Lundbeck LLC | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-07-24 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-07-17 | Supernus Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-06-19 | Eisai Inc. | $20 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2024 | |
| 2024-05-29 | Tris Pharma Inc | $19 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-05-16 | Corium, LLC | $19 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-05-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-14 | Axsome Therapeutics, Inc. | $102 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-05-09 | Alkermes, Inc. | $13 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-04-24 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-24 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-04-19 | Alkermes, Inc. | $14 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-04-17 | IDORSIA PHARMACEUTICALS US INC | $17 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, Insomnia | 2024 | |
| 2024-03-20 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-03-13 | Noven Therapeutics, LLC | $22 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2024 | |
| 2024-02-14 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-02-07 | Validus Pharmaceuticals LLC | $16 | Food and Beverage | Cash or cash equivalent | Equetro Drug, CNS | 2024 | |
| 2024-01-24 | Neos Therapeutics, LP | $18 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2024 | |
| 2024-01-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-11 | Janssen Pharmaceuticals, Inc | $81 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-01-10 | Biogen, Inc. | $14 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2024 | |
| 2024-01-03 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2023-12-06 | Neurocrine BioSciences, Inc. | $102 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-11-29 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-11-23 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-11-15 | Noven Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Secuado Drug, CNS Psychiatry | 2023 | |
| 2023-11-01 | Corium, LLC | $32 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-11-01 | Neurocrine BioSciences, Inc. | $5 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-27 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-10-18 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-11 | Janssen Pharmaceuticals, Inc | $27 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-09-27 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-09-20 | Tris Pharma Inc | $19 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2023 | |
| 2023-09-13 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-08-30 | Noven Therapeutics, LLC | $17 | Food and Beverage | In-kind items and services | Secuado Drug, CNS Psychiatry | 2023 | |
| 2023-08-01 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-07-20 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-07-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-22 | Almatica Pharma LLC | $18 | Food and Beverage | In-kind items and services | SERTRALINE HCL Drug, ANTI-DEPRESSION | 2023 | |
| 2023-06-19 | Teva Pharmaceuticals USA, Inc. | $91 | Education | In-kind items and services | 2023 | ||
| 2023-05-24 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-04-19 | Corium, LLC | $24 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2023 | |
| 2023-04-05 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-03-20 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | HETLIOZ Drug, NON-24-HOUR SLEEP-WAKE DISORDER | 2023 | |
| 2023-02-22 | Validus Pharmaceuticals LLC | $35 | Food and Beverage | Cash or cash equivalent | Equetro Drug, CNS | 2023 | |
| 2023-02-17 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-02-08 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-01-18 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2023 | |
| 2022-12-22 | IDORSIA PHARMACEUTICALS US INC | $20 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2022 | |
| 2022-12-14 | Axsome Therapeutics, Inc. | $25 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2022 | |
| 2022-12-10 | Janssen Pharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-12-07 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-12-01 | Corium, LLC | $22 | Food and Beverage | In-kind items and services | AZSTARYS Drug, CNS Stimulant for ADHD | 2022 | |
| 2022-11-23 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2022 | |
| 2022-11-16 | Sunovion Pharmaceuticals Inc. | $21 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-11-16 | Sunovion Pharmaceuticals Inc. | $0 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-11-16 | Sunovion Pharmaceuticals Inc. | $0 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-11-10 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-10-12 | Sunovion Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-10-12 | Sunovion Pharmaceuticals Inc. | $0 | Food and Beverage | In-kind items and services | LATUDA Drug, CNS | 2022 | |
| 2022-09-07 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2022 | |
| 2022-08-24 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2022 | |
| 2022-08-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2022 |
The latest 200 records of 371.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Euless, TX, county Tarrant County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Euless, TX | County Tarrant County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 60,421 | 2,167,390 | 30,188,424 |
| Population, 2020 census P1 | 61,032 | 2,110,640 | 29,145,505 |
| Median age B01002 | 34.8 | 35.2 | 35.6 |
| Under 18 B01001 | 24.2% | 25.4% | 25.0% |
| 65 and over B01001 | 11.2% | 12.3% | 13.4% |
| Households B11001 | 23,899 | 782,419 | 10,992,816 |
| Foreign born B05002 | 21.2% | 17.2% | 17.6% |
| Median household income B19013 | $82,167 | $84,207 | $78,476 |
| Median family income B19113 | $97,028 | $102,307 | $94,599 |
| Per capita income B19301 | $41,178 | $42,755 | $40,752 |
| Poverty rate B17001 | 7.8% | 11.1% | 13.8% |
| Unemployment rate B23025 | 5.5% | 4.7% | 5.3% |
| Civilian labor force B23025 | 36,357 | 1,156,004 | 15,233,563 |
| Mean commute (minutes) B08013 | 24.8 | 26.8 | 26.7 |
| Bachelor's degree or higher B15003 | 39.8% | 34.8% | 33.8% |
| Housing units B25001 | 25,795 | 843,257 | 12,128,515 |
| Owner-occupied B25003 | 39.8% | 59.3% | 62.6% |
| Renters B25003 | 60.2% | 40.7% | 37.4% |
| Median home value B25077 | $318,800 | $323,900 | $283,800 |
| Median gross rent B25064 | $1,690 | $1,547 | $1,403 |
| White, not Hispanic B03002 | 37.3% | 42.0% | 39.1% |
| Black B03002 | 17.2% | 17.3% | 11.9% |
| Hispanic or Latino B03002 | 22.3% | 30.3% | 39.7% |
| Asian B03002 | 13.3% | 6.1% | 5.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Euless, TX.
Comments